Revenue (Annual) Chart

View Revenue (Annual) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 8.251B
December 31, 2024 8.189B
December 31, 2023 8.120B
December 31, 2022 7.741B
December 31, 2021 5.481B
December 31, 2020 2.797B
December 31, 2019 2.806B
December 31, 2018 2.596B
December 31, 2017 1.758B
December 31, 2016 1.666B
December 31, 2015 1.575B
December 31, 2014 1.503B
December 31, 2013 1.336B
December 31, 2012 1.115B
December 31, 2011 945.73M
Date Value
December 31, 2010 900.04M
December 31, 2009 887.61M
December 31, 2008 865.25M
December 31, 2007 630.72M
December 31, 2006 455.60M
December 31, 2005 346.20M
May 31, 2005
May 31, 2004 296.92M
May 31, 2003 225.72M
May 31, 2002 156.56M
May 31, 2001 116.16M
May 31, 2000 80.77M
May 31, 1999 71.90M
May 31, 1998 53.09M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Proteome Sciences Plc 4.95M
Champions Oncology, Inc. 59.42M
Medpace Holdings, Inc. 2.530B
Avantor, Inc. 6.552B
Personalis, Inc. 69.65M